Express Scripts Margins Could Face Downward Pressure From Less Prescription Growth

By: via Benzinga
Argus' David Toung reiterated Express Scripts Holding Company (NASDAQ: ESRX)'s Hold rating after forecasting slow prescription growth ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.